Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BioSig Technologies, Inc. stock logo
BSGM
BioSig Technologies
$6.19
-3.1%
$3.07
$0.23
$8.80
$168.96M1.66316,710 shs673,351 shs
Electromed, Inc. stock logo
ELMD
Electromed
$20.12
+0.2%
$21.64
$13.74
$35.56
$168.73M0.473,249 shs50,390 shs
Second Sight Medical Products, Inc. stock logo
EYES
Second Sight Medical Products
$5.67
$3.42
$12.72
$54.38M2.55132,982 shs36,800 shs
Pheton Holdings Ltd Class A Ordinary Shares stock logo
PTHL
Pheton Holdings Ltd Class A Ordinary Shares
$17.77
+2.8%
$6.09
$1.32
$19.05
$116.96MN/A221,863 shs393,841 shs
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BioSig Technologies, Inc. stock logo
BSGM
BioSig Technologies
-3.13%-1.75%+137.16%+839.30%+1,275.86%
Electromed, Inc. stock logo
ELMD
Electromed
+0.25%+1.51%-6.64%-18.38%+38.57%
Second Sight Medical Products, Inc. stock logo
EYES
Second Sight Medical Products
0.00%0.00%0.00%0.00%0.00%
Pheton Holdings Ltd Class A Ordinary Shares stock logo
PTHL
Pheton Holdings Ltd Class A Ordinary Shares
+2.78%+18.47%+236.87%+401.98%+1,776,999,900.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
BioSig Technologies, Inc. stock logo
BSGM
BioSig Technologies
2.5109 of 5 stars
3.50.00.00.04.00.80.6
Electromed, Inc. stock logo
ELMD
Electromed
1.1577 of 5 stars
2.05.00.00.00.61.70.0
Second Sight Medical Products, Inc. stock logo
EYES
Second Sight Medical Products
N/AN/AN/AN/AN/AN/AN/AN/A
Pheton Holdings Ltd Class A Ordinary Shares stock logo
PTHL
Pheton Holdings Ltd Class A Ordinary Shares
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
BioSig Technologies, Inc. stock logo
BSGM
BioSig Technologies
3.00
Buy$10.0061.55% Upside
Electromed, Inc. stock logo
ELMD
Electromed
4.00
Strong Buy$38.0088.87% Upside
Second Sight Medical Products, Inc. stock logo
EYES
Second Sight Medical Products
0.00
N/AN/AN/A
Pheton Holdings Ltd Class A Ordinary Shares stock logo
PTHL
Pheton Holdings Ltd Class A Ordinary Shares
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest EYES, BSGM, ELMD, and PTHL Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/6/2025
BioSig Technologies, Inc. stock logo
BSGM
BioSig Technologies
Ascendiant Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$2.50 ➝ $10.00
5/15/2025
Electromed, Inc. stock logo
ELMD
Electromed
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
4/21/2025
BioSig Technologies, Inc. stock logo
BSGM
BioSig Technologies
Ascendiant Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$2.75 ➝ $2.50
(Data available from 6/17/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
BioSig Technologies, Inc. stock logo
BSGM
BioSig Technologies
$26K6,498.31N/AN/A($0.33) per share-18.76
Electromed, Inc. stock logo
ELMD
Electromed
$61.44M2.75$0.49 per share41.36$5.10 per share3.95
Second Sight Medical Products, Inc. stock logo
EYES
Second Sight Medical Products
$3.38M0.00N/AN/A$4.80 per share0.00
Pheton Holdings Ltd Class A Ordinary Shares stock logo
PTHL
Pheton Holdings Ltd Class A Ordinary Shares
$448.20K260.96N/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
BioSig Technologies, Inc. stock logo
BSGM
BioSig Technologies
-$29.04MN/A0.00N/AN/A-44,832.50%N/A-776.49%8/13/2025 (Estimated)
Electromed, Inc. stock logo
ELMD
Electromed
$5.15M$0.7926.83N/A11.34%15.71%13.37%N/A
Second Sight Medical Products, Inc. stock logo
EYES
Second Sight Medical Products
-$8.92MN/A0.00N/AN/AN/A-13.58%-13.02%N/A
Pheton Holdings Ltd Class A Ordinary Shares stock logo
PTHL
Pheton Holdings Ltd Class A Ordinary Shares
N/AN/A0.00N/AN/AN/AN/AN/A

Latest EYES, BSGM, ELMD, and PTHL Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/19/2025Q1 2025
BioSig Technologies, Inc. stock logo
BSGM
BioSig Technologies
-$0.05-$0.14-$0.09-$0.14N/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
BioSig Technologies, Inc. stock logo
BSGM
BioSig Technologies
N/AN/AN/AN/AN/A
Electromed, Inc. stock logo
ELMD
Electromed
N/AN/AN/AN/AN/A
Second Sight Medical Products, Inc. stock logo
EYES
Second Sight Medical Products
N/AN/AN/AN/AN/A
Pheton Holdings Ltd Class A Ordinary Shares stock logo
PTHL
Pheton Holdings Ltd Class A Ordinary Shares
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
BioSig Technologies, Inc. stock logo
BSGM
BioSig Technologies
N/A
0.50
0.50
Electromed, Inc. stock logo
ELMD
Electromed
N/A
5.10
4.74
Second Sight Medical Products, Inc. stock logo
EYES
Second Sight Medical Products
N/A
22.15
22.15
Pheton Holdings Ltd Class A Ordinary Shares stock logo
PTHL
Pheton Holdings Ltd Class A Ordinary Shares
N/AN/AN/A
CompanyEmployeesShares OutstandingFree FloatOptionable
BioSig Technologies, Inc. stock logo
BSGM
BioSig Technologies
5027.30 million14.30 millionNo Data
Electromed, Inc. stock logo
ELMD
Electromed
1608.39 million7.36 millionOptionable
Second Sight Medical Products, Inc. stock logo
EYES
Second Sight Medical Products
1513.14 million6.94 millionOptionable
Pheton Holdings Ltd Class A Ordinary Shares stock logo
PTHL
Pheton Holdings Ltd Class A Ordinary Shares
116.58 millionN/AN/A

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
BioSig Technologies stock logo

BioSig Technologies NASDAQ:BSGM

$6.19 -0.20 (-3.13%)
Closing price 06/16/2025 04:00 PM Eastern
Extended Trading
$6.45 +0.26 (+4.20%)
As of 04:02 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

BioSig Technologies, Inc., together with its subsidiaries, a medical device company, engages in development and commercialization of advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias in the United States. It offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with Mayo Foundation to develop an AI- and machine learning-powered software for PURE EP system. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.

Electromed stock logo

Electromed NYSE:ELMD

$20.12 +0.05 (+0.25%)
Closing price 06/16/2025 04:00 PM Eastern
Extended Trading
$20.20 +0.08 (+0.42%)
As of 06/16/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products to hospitals, home health care centers, pulmonary rehabilitation centers, cystic fibrosis centers, neuromuscular clinics, and other clinics through distributors. It markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.

Second Sight Medical Products stock logo

Second Sight Medical Products NASDAQ:EYES

Second Sight Medical Products, Inc. develops, manufactures, and markets implantable visual prosthetics that are intended to deliver artificial vision to blind individuals. It develops technologies to treat the population of sight-impaired individuals. The company offers the Orion Visual Cortical Prosthesis System, an implanted cortical stimulation device, which is intended to provide useful artificial vision to individuals who are blind due to various causes, including glaucoma, diabetic retinopathy, optic nerve injury or disease, and eye injury. The company was founded in 1998 and is headquartered in Sylmar, California.

Pheton Holdings Ltd Class A Ordinary Shares stock logo

Pheton Holdings Ltd Class A Ordinary Shares NASDAQ:PTHL

$17.77 +0.48 (+2.78%)
Closing price 06/16/2025 04:00 PM Eastern
Extended Trading
$17.56 -0.22 (-1.21%)
As of 04:43 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Pheton Holdings Ltd. operates as a holding company with interests in providing healthcare solutions. The firm through its subsidiaries engages in the development and commercialization of brachytherapy TPS specifically used for radioactive particle implantation, a type of radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company was founded in 1998 and is headquartered in Beijing, China.